Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

PMGC Holdings Inc. (ELAB) vs Jaguar Animal Health, Inc. (JAGX)

PMGC Holdings Inc. and Jaguar Animal Health, Inc. are both Biotechnology companies. PMGC Holdings Inc. and Jaguar Animal Health, Inc. are of similar size ($3.8M and $3.7M). PMGC Holdings Inc. has negative trailing earnings, so its P/E is not meaningful; Jaguar Animal Health, Inc. trades at 0.1×. Jaguar Animal Health, Inc. grew revenue faster over the last twelve months: 135.5% against 5.41%. Jaguar Animal Health, Inc. has the higher net margin (−188.5% vs −523.0%) and the lower return on invested capital (−28,393.6% vs 0.00%). Across the 17 metrics below, Jaguar Animal Health, Inc. leads on 9 and PMGC Holdings Inc. on 8.

Valuation

Metric ELAB JAGX Biotechnology median
P/E n/m 0.06 7.88
P/S 0.85 0.22 11.47
P/B 0.13 1.27 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 1.45 n/m 0.74
EV/Sales (6.33) 0.19 10.73
Earnings yield (23,768.66%) 1,566.54% (28.84%)
Free cash flow yield (411.61%) (118.33%) (23.03%)

Profitability

Metric ELAB JAGX Biotechnology median
Gross margin 31.08% 82.31% 65.16%
Operating margin (458.63%) (93.10%) 0.00%
Net margin (522.99%) (188.46%) 0.00%
Free cash flow margin (348.69%) (24.03%) 0.00%
Return on equity (104.60%) (1,125.38%) (57.72%)
Return on assets (58.71%) (127.14%) (49.22%)
Return on invested capital 0.00% (28,393.64%) 0.00%

Growth

Metric ELAB JAGX Biotechnology median
Revenue growth (TTM) 5.41% 135.52% 5.64%
EPS growth (last fiscal year) 94.22% 82.42% —
Revenue growth, 5-year CAGR — 4.17% 8.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ELAB JAGX Biotechnology median
Debt to equity 0.02 0.35 0.00
Current ratio 1.36 0.69 4.73
Net debt to EBITDA 0.87 (0.17) 0.96

Dividend

Metric ELAB JAGX Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric ELAB JAGX Biotechnology median
Market cap 3.66m 3.80m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack